Yvette, France

Elsa P Bianchini

This inventor holds 2 USPTO granted patents. Top assignees: The Children's Hospital of Philadelphia, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012-2015.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Villebon/Yvette, FR (2012)
  • Yvette, FR (2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Elsa P Bianchini

Introduction

Elsa P Bianchini is a notable inventor based in Yvette, France. She has made significant contributions to the field of hemostasis through her innovative research and patents. With a total of 2 patents, her work focuses on novel thrombin/prothrombin protease/zymogen variants that exhibit anticoagulation activity.

Latest Patents

Bianchini's latest patents include compositions and methods for modulating hemostasis. These patents disclose novel thrombin/prothrombin protease/zymogen variants that have anticoagulation activity and methods of use thereof. Her research is pivotal in advancing medical treatments related to blood coagulation.

Career Highlights

Throughout her career, Elsa P Bianchini has worked with esteemed organizations such as the United States of America, as represented by the Secretary, Department of Health and Human Services, and The Children's Hospital of Philadelphia. Her work in these institutions has allowed her to contribute significantly to medical research and innovation.

Collaborations

Bianchini has collaborated with notable professionals in her field, including Sriram Krishnaswamy and Steven J Orcutt. These collaborations have further enhanced her research and the impact of her inventions.

Conclusion

Elsa P Bianchini's contributions to the field of hemostasis through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical science and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…